6 / 7
Research & Reviews: Journal of Medical and Health Sciences
ISSN: 2319-9865
October 08-09, 2018
Edinburgh, Scotland
Pathology 2018
Page 38
17
th
International Conference on
Pathology & Cancer
Epidemiology
B
one marrow specimens play a crucial role in the diagnosis of
hematolymphoidneoplasms.Although withinthepast50years
significant advances have been made in immunophenotyping,
cytogenetics, FISH, and molecular sciences, morphological
examination of bone marrow still remains the primordial mean
for diagnosing hematolymphoid disorders. Furthermore, based
on the morphological findings, all other ancillary testings are
directed. Therefore, an adequate bone marrow specimen plays
a critical role not only in the morphological examination of the
marrow, but in judiciously selecting the additional necessary
tests to reach a final conclusion, meaningful for oncologists to
properly treat their patients. In this presentation the audience
will be introduced to the many artifacts that may preclude an
adequate bone marrow examination and how they could be
avoided.
Biography
Adrian M Padurean currently the Medical Director of the NeoGenomics Lab-
oratories, Fort Myers, Florida, received his medical degree from University of
Medicine Victor Babes, Timisoara, Romania. He conducted medical research
at Massachusetts General Hospital/Harvard Medical School and Mount Sinai
Medical Center, New York, completed his pathology residency at Regions Hos-
pital in St. Paul, Minnesota and hematopathology fellowship at the University of
Minnesota. He served as Assistant Professor at University of Minnesota Med-
ical School, Minneapolis, and subsequently was Director of Hematology Labo-
ratories of Wheaton Franciscan Healthcare, Milwaukee, Wisconsin. He earned
an MBA in Healthcare Administration from the Quinlan School of Business at
Loyola University Chicago.
adrian.padurean@neogenomics.comHow would you like your bone
marrow, well done?
Adrian M Padurean
NeoGenomics Laboratories, Fort Myers, USA
Adrian M Padurean, RRJMHS 2018
Volume: 7